3,851
Views
16
CrossRef citations to date
0
Altmetric
Laboratory Study

Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation

, , , & ORCID Icon
Pages 803-810 | Received 05 Oct 2020, Accepted 02 Apr 2021, Published online: 10 May 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.